Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy

PURPOSE: Patients with metastatic uveal melanoma have limited therapeutic options and high mortality rate so new treatment options are needed. PATIENTS AND METHODS: We previously reported that patients treated with the PD-1 inhibitor pembrolizumab and the histone deacetylase inhibitor entinostat in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sah, Vasu R., Jespersen, Henrik, Karlsson, Joakim, Nilsson, Lisa M., Bergqvist, Mattias, Johansson, Iva, Carneiro, Ana, Helgadottir, Hildur, Levin, Max, Ullenhag, Gustav, Ståhlberg, Anders, Olofsson Bagge, Roger, Nilsson, Jonas A., Ny, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194136/
https://www.ncbi.nlm.nih.gov/pubmed/37377898
http://dx.doi.org/10.1158/2767-9764.CRC-22-0490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194136/
https://www.ncbi.nlm.nih.gov/pubmed/37377898
http://dx.doi.org/10.1158/2767-9764.CRC-22-0490

Ejemplares similares